Mrázková Lucie, Hladoníková Klaudia, Toncarová Barbora, Fischer Michal, Zýka Jakub, Kozák Jaroslav, Kráľ Michal, Kožíšek Milan, Jiráček Jiří, Kaminský Jakub, Parkan Kamil, Žáková Lenka
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 542/2, Prague, 160 00, Czech Republic.
Department of Cell Biology, Faculty of Science, Charles University, Viničná 7, Prague, 128 00, Czech Republic.
Chemistry. 2025 Jul 22;31(41):e202500973. doi: 10.1002/chem.202500973. Epub 2025 May 20.
The cation-independent mannose-6-phosphate/IGF2 receptor (CI-M6P/IGF2R) plays a crucial role in transporting lysosomal enzymes and other ligands. In this study, we designed and synthesized novel stable mannose-6-phosphate (M6P) derivatives to enhance their affinity for CI-M6P/IGF2R. To evaluate the binding potency, we employed a sensitive and cost-effective fluorescence polarization assay, enabling rapid quantification of receptor-ligand interactions in solution. The tested compounds included di-, tri-, and penta-M6P peptides along with various M6P-derived small molecules featuring phosphate isosteres or other functional modifications. Our findings indicate that ligands bearing multiple M6P moieties exhibit significantly higher receptor affinities than monomeric compounds and that phosphonate groups may serve as a more stable and potent alternative to native M6P. Computational modeling of ligand interactions with the CI-M6P/IGF2R domains further elucidated the binding mechanisms, offering new directions for the development of more effective ligands. This study advances the design of therapeutic strategies that leverage CI-M6P/IGF2R for targeted biomolecule delivery to lysosomes, thereby opening new possibilities for biomedical applications.
不依赖阳离子的甘露糖-6-磷酸/胰岛素样生长因子2受体(CI-M6P/IGF2R)在转运溶酶体酶和其他配体方面发挥着关键作用。在本研究中,我们设计并合成了新型稳定的甘露糖-6-磷酸(M6P)衍生物,以增强它们与CI-M6P/IGF2R的亲和力。为了评估结合效力,我们采用了一种灵敏且经济高效的荧光偏振测定法,能够快速定量溶液中受体-配体的相互作用。测试的化合物包括二聚体、三聚体和五聚体M6P肽以及各种具有磷酸酯类似物或其他功能修饰的M6P衍生小分子。我们的研究结果表明,带有多个M6P基团的配体比单体化合物表现出显著更高的受体亲和力,并且膦酸酯基团可能作为天然M6P更稳定且有效的替代物。配体与CI-M6P/IGF2R结构域相互作用的计算模型进一步阐明了结合机制,为开发更有效的配体提供了新方向。本研究推进了利用CI-M6P/IGF2R进行靶向生物分子向溶酶体递送的治疗策略设计,从而为生物医学应用开辟了新的可能性。